Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Crossover Trial in PCOS
NCT02280057Phase 4Completed
- Sponsor
- Regionshospitalet Herning
- Start
- Sep 2001
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Regionshospitalet Herning. Primary endpoint: Levels of free testosterone at 6 months. Started Sep 2001; status: completed.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02280057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280057.